Related Experiment Video

Updated: Sep 13, 2025

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.5K

Resistant Mycoplasma pneumoniae in children

Caeleigh Smith, Karin Ng, Kendra Sih

    Canadian Family Physician Medecin De Famille Canadien
    |July 29, 2025
    PubMed

    Insights

    Macrolide-resistant Mycoplasma pneumoniae pneumonia is rising globally. For children unresponsive to macrolides, especially after travel to high-resistance areas, doxycycline is the recommended treatment.

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Microbiology

    Background:

    • Community-acquired pneumonia is common in children.
    • Macrolide-resistant Mycoplasma pneumoniae (MRMP) is an emerging global health concern.
    • Increasing MRMP rates are noted, particularly in East Asian countries.

    Purpose of the Study:

    • To review current evidence for treating macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    • To provide treatment recommendations for pediatric MRMP cases, especially those with treatment failure or travel history.

    Main Methods:

    • Literature review of available evidence on MRMP treatment in pediatric populations.
    • Analysis of treatment outcomes for different antibiotic classes.

    Main Results:

    • Tetracyclines demonstrate the strongest evidence for treating MRMP in children.
    • Fluoroquinolones show more limited evidence for MRMP treatment.
    • Doxycycline is recommended at 2 mg/kg twice daily (max 100 mg/dose) for MRMP.

    Conclusions:

    • Macrolide resistance in Mycoplasma pneumoniae is a growing worldwide issue.
    • Doxycycline is the preferred treatment for pediatric MRMP, particularly in cases of treatment failure or recent travel to endemic regions.
    • Prompt recognition and appropriate antibiotic selection are crucial for managing MRMP.
    Abstract

    More Related Videos

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014

    15.2K
    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

    A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

    Published on: January 2, 2017

    14.8K

    Related Concept Videos

    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
    2.5K
    Pneumonia I: Introduction01:30

    Pneumonia I: Introduction

    Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
    Risk Factors
    Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
    331
    Pneumonia III: Complications and Assessment01:30

    Pneumonia III: Complications and Assessment

    Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
    442
    Pneumonia II: Pathophysiology01:29

    Pneumonia II: Pathophysiology

    The pathophysiology of pneumonia involves the following steps:
    565
    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    451
    Bacterial Phylum Tenericutes01:24

    Bacterial Phylum Tenericutes

    The phylum Tenericutes, which includes the single class Mollicutes, comprises bacteria that lack cell walls. The term "Mollicutes" derives from the Latin word mollis, meaning "soft." These organisms are among the smallest known and are commonly referred to as mycoplasmas due to the prominence of the genus Mycoplasma, which includes well-known human pathogens. Despite their inability to stain gram-positively (a result of their lack of cell walls), mycoplasmas are phylogenetically related to the...
    93